- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2014
- Public Summary Document (PSD) July 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2014 PBAC Meeting - Word
Adalimumab – July 2014
Adalimumab, 40mg/0.8mL injection, 0.8 mL cartridges and 0.8mL syringes, Humira®
Last updated
8 November 2023